Transforming growth factor beta as a clinical biomarker for prostate cancer

Urology

Volumn 49, Issue 1, 1997, Pages 151-155

  Perry, Kent T ^a   Anthony, Catherine T ^a   Case, Tom ^a   Steiner, Mitchell S ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 0031019319     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00426-8     Document Type: Article

References (17)

1. Steiner MS: Review of peptide growth factors in benign prostatic hyperplasia and urologie malignancy. J Urol 153: 1085-1096, 1995.
2. Yang EY, and Moses HL: Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111: 731-741, 1990.
3. Fontana A, Constam DB, Frei K, Malipiero U, and Pfister HW: Modulation of the immune response by transforming growth factor beta. Int Arch Allergy Appl Immunol 99: 1-7, 1992.
4. Newman MJ: Transforming growth factor beta and the cell surface in tumor progression. Cancer Metastasis Rev 12: 239-254, 1993.
5. Ikeda T, Lioubin MN, and Marquardt H: Human transforming growth factor type beta-2: production by a prostatic adenocarcinoma cell line, purification and initial characterization. Biochemistry 26: 2406-2410, 1987.
6. Knabbe C, Klein H, Zugmaier G, and Voigt KD: Hormonal regulation of transforming growth factor-β2 expression in human prostate cancer. J Steroid Biochem Mol Biol 4: 137-142, 1993.
7. Madisen L, Webb NR, Rose TM, Marquardt H, Ikeda T, Twardzik D, Seyedin S, and Purchio AF: Transforming growth factor-β2: cDNA cloning and sequence analysis. DNA 7: 1-8, 1988.
8. Moses HL, Yang EY, and Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
9. Nilsen-Hamilton M: Transforming growth factor-beta and its actions on cellular growth and differentiation. Curr Top Dev Biol 24: 95-136, 1990.
10. Ivanovic V, Melman A, Davis-Joseph B, Valcic M, and Geliebter J: Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nature Med 1: 282-284, 1995.
11. Gouri R, Lyons R, Jiang N, and Moses H: TGF-β in normal human urine. Biochem Biophys Res Commun 148: 1503-1512, 1987.
12. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, and Berger WH: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712, 1987.
13. Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, and Park SH: Transforming growth factor β1 as a biomarker for prostate cancer. J Cell Biochem 16H: 54-61, 1992.
14. Troung LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, and Thompson TC: Association of transforming growth factor-β with prostate cancer: an immunohistochemical study. Hum Pathol 24: 4-9, 1993.
15. Steiner MS, Zhou Z, Tonb DC, and Barrack ER: Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 135: 2240-2247, 1994.
16. Miyazono K, Hellman U, Wernstedt C, and Carl-Henrik H: Latent high molecular weight complex of transforming growth factor β1: purification from human platelets and structural characterization. J Biol Chem 263: 6407-6415, 1988.
17. Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, and Thompson TC: Elevated transforming growth factor-β1 and β3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression. Mol Endocrinol 5: 503-513, 1991.